Ocular rosacea

This MedLibrary.org supplementary page on Ocular rosacea is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Ocular rosacea is a manifestation of rosacea that affects the eyes and eyelids. Symptoms generally consist of redness, irritation or burning of the eyes. Patients may also feel that there is something, such as an eyelash, in the eye. Commonly patients also show redness of the nose and cheeks.

Patients who suffer from ocular rosacea may be treated with warm compresses, artificial tears and washing the area around the eye with warm water, including the eyelids, to help alleviate symptoms. Additionally, oral antibiotics, typically doxycycline, may be prescribed. Some patients feel that dietary restrictions of caffeine, spicy foods, and Alcoholic beverages may reduce or eliminate symptoms.

See also

References

  • Kunimoto, Derek Y, et al. The Wills Eye Manual, 4th ed. Lippincott, Philiadelphia.2004.

A more up to date source of information, and more references can be found at this website which is a branch of WebMD:

http://www.emedicine.com/OPH/topic115.htm

Wikipedia content modification information:

  • This page was last modified on 25 July 2008, at 16:40.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Ocular rosacea".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.